View more on these topics

Where next for structured products?

Money Marketing will be reporting on the outlook for structured products at a roundtable hosted by Barclays Wealth on Wednesday 27 January. 

Attendees include:

Colin Dickie, Barclays Wealth
Marc Chamberlain, Morgan Stanley
Gary Dale, Investec
Bill Vasilieff, Novia
Ian Lowes, Lowes Financial Management
Bruce Wilson, Helm Godfrey
Julie Smith, Fair Investment

Please contact hannah.stodell@centaur.co.uk with any questions you would like the Money Marketing team to put to the panel on the day.  

Recommended

John Joe McGinley, Business strategy manager Aegon

Mad about the plan

The definition of insanity is doing the same thing over and over again and expecting a different result but by following a business plan, we can change the outcome

Dalton-Brown: Barclays’ move

Dalton Brown joins Barclays Wealth to head fund range

Barclays Wealth has recruited former Fidelity FundsNetwork chief David Dalton-Brown as head of Barclays Wealth Funds. He left Fidelity FundsNetwork in October after five years at the firm. He will be responsible for the establishment and maintenance of Barclays Wealth’s fund ranges, implementation of the product, client service delivery and the quality of the control […]

Value remains within European equities

By Rob Burnett, Neptune European Opportunities Fund

In recent months, investors have become more pessimistic about both the European and the US economic outlook and yet stockmarkets have pushed on to new highs. Some would argue that this is a worrying divergence. We would take the opposite view. This appears to be classic bull market behaviour. A wall of worry has been rebuilt, and stockmarket resilience should be taken as a sign of strength. The market is discounting an improving economic outlook ahead, particularly in the south of Europe.

Newsletter

News and expert analysis straight to your inbox

Sign up

Comments

There are 2 comments at the moment, we would love to hear your opinion too.

  1. An informed and constructive debate about structured products is no bad thing, though I really cannot understand why some people seem to have such an irrational hatred of them.

    They are by no means suitable for all types of client or all phases in investment markets and nor are they risk free. But, provided the risk is understood, the counterparty is sound and due account is taken of the fact that the collapse of Lehmann Bros was an extremely rare event (not to mention one that the Fed, not long after, regretted having allowed to happen), they have their place.

    For the most part, in my experience, they do deliver what they say on the tin that they hope or aim (not promise) to.

    Stay away from complicated ones that depend on the performance of more than one index to deliver the goods and, for the most part, they’re a pretty sound bet. Only the ones that look too good to be true, like most things, nearly always are.

  2. I would like to know how Keydata managed to sell ISA’s for 6 years, which were never approved by HMRC?

    How can we be sure that this wont happen again, given that the Regulator (FSA) has stated that it’s not their job to check the products of the firms it regulates?

Leave a comment